Usefulness of liver biopsy in chronic hepatitis C

Annals of Hepatology

Volumn 9, Issue SUPPL. 1, 2010, Pages 39-42

  Strauss, Edna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biopsy limitations; Chronic hepatitis C; Fibrosisdegree; Liver biopsy; Liver disease; Treatment indications

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; BLEEDING; BLOOD CLOTTING DISORDER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISPOSABLE EQUIPMENT; FATTY LIVER; GOLD STANDARD; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER HILUS; LIVER SIZE; MINIMALLY INVASIVE PROCEDURE; NEEDLE; PERCUTANEOUS BIOPSY; PROTHROMBIN TIME; SAMPLING ERROR; SHOULDER PAIN; TISSUE SLICE; HOSPITALIZATION; INSTRUMENTATION; LIVER; LIVER CIRRHOSIS; NEEDLE BIOPSY; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; VIROLOGY;

BIOPSY, NEEDLE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; NEEDLES; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 79751491648     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31722-3     Document Type: Article

References (12)

1. Menghini G. One-second needle biopsy of the liver. Gastroeterology 1958; 35: 190-199.
2. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-244.
3. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481.
4. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
5. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004; 24: 89-97.
6. Rousselet M, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-264.
7. Patel K, Nelson DR, Rockey DC, et al. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C. Clin Gastroenterol Hepatol 2008; 6: 242-247.
8. Viana MSVB, Takei K, Yamaguti DCC; Guz B, Strauss E. Use of AST platelet indrex (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Ann Hepatol 2009; 8: 26-31.
9. Alric L, Kamar N, Bonnet D, et al. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Transpl Int 2009; 22: 568-573.
10. Persico M, Perrotta S, Persico E, et al. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years. J Viral Hepatol 2006; 13: 290-296.
11. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of the Liver. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
12. Bedossa P, Moucari R, Chelbi E, et al. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Hepatology 2007; 46: 380-387.